Latest Asset Management News

Triton Minerals reports encouraging geological signs from its maiden drilling at the Aucu Gold-Copper Project despite operational hurdles, while legal delays stall the completion of its 70% graphite asset sale.

Biotron Limited has closed its non-renounceable rights issue, raising $645,861 to advance its Hepatitis B virus drug development, with a shortfall commitment from Peak Asset Management still pending.

Qube Holdings has confirmed that Macquarie Asset Management has met the conditions to extend their exclusivity period, keeping potential deal talks alive but without any guarantee of a binding agreement.

Qube Holdings has sold its 202-hectare Beveridge property interest for $111 million, booking a substantial $100 million pre-tax profit in FY26. The move frees Qube from development costs while keeping future operational options open.

Perpetual Limited has extended its exclusivity agreement with Bain Capital into early 2026 as discussions continue over the potential sale of its Wealth Management business. While progress is steady, no binding deal is yet assured.

DigitalX Limited reports a robust $82.1 million treasury portfolio in November 2025, maintaining significant Bitcoin exposure and demonstrating resilience through strategic investments amid market volatility.

Magellan Asset Management has launched the Magellan Infrastructure Fund (Currency Hedged), an actively managed ETF trading on the ASX under ticker MICH, targeting global listed infrastructure with currency hedging and ESG integration.

Revolution Private Credit Income Trust has reported a solid $3.4 million operating profit for its inaugural half-year period, delivering a net return of 0.93% since listing and outperforming its benchmark. The Trust also declared a distribution of 0.35 cents per unit for October 2025.

MFF Capital Investments appoints Gerald Stack as CEO and Managing Director, signaling a strategic evolution with a proposed dividend increase to 10 cents per share.

Group 6 Metals Limited has updated its quarterly cash flow report, excluding certain financing from working capital calculations, while confirming sufficient funding and forecasting improved operational cash flows.

InhaleRx Limited has secured $427,500 from an initial tranche of its $1 million capital raise, issuing 17.1 million shares to support its inhaled therapies targeting pain and mental health conditions.

Emeco Group reveals a robust FY25 with $785 million revenue, nearly half from its expanding maintenance services, underpinned by advanced asset management technology and a strategic push into new sectors.